CBD Life Sciences, Inc. (CBDL) Releases Letter to Shareholders
CBD Life Sciences (OTC PINK:CBDL) announced strategic initiatives in a letter to shareholders. The company plans to acquire new retail locations and vending machines across the United States, citing strong initial revenue from its first vending machine in Tanger Outlets, AZ. CEO Lisa Nelson revealed ongoing efforts to establish a 20,000 sq ft indoor Hemp Facility and hinted at a potential partnership in cryptocurrency mining. Additionally, product expansion in Europe is anticipated by spring 2022. CBD Life Sciences aims to keep shareholders informed as the company grows.
- Plans for acquiring new retail locations and vending machines may enhance revenue streams.
- Successful test run with first vending machine generating significant revenue.
- Ongoing search for a 20,000 sq ft indoor Hemp Facility demonstrates growth intentions.
- Potential partnership in cryptocurrency mining may diversify business operations.
- Expanding product offerings in Europe expected to boost market presence.
- None.
SCOTTSDALE, AZ / ACCESSWIRE / January 26, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company will be releasing a letter to its fellow shareholders.
CBD Life Sciences Inc. has been sharpening its strategic focus in several ways and 2022 is going to be a big year for the company to say the least. The company has been looking into acquiring more locations for retail for quite some time now and finally there are a few spots that are in interest which is great news! Along with retail locations, CBD Life Sciences Inc. has been looking to purchase more vending machines to put into various locations across the United States. President & CEO Lisa Nelson states "After placing our first machine in Tanger Outlets located in Glendale, AZ, we have been seeing significant revenue generate, so this was sort of a test run before we start purchasing multiple machines." Lisa Nelson also stated, "Our team is currently in the process of locating a 20,000 sq ft indoor Hemp Facility for all of our needs as we are constantly expanding." Later in the upcoming months, CBD Life Sciences Inc. may have a possible partnership lined up with a company that has to do with cryptocurrency mining so that will be explosive if everything goes as planned. As far as the expansion of products in Europe goes, this will hopefully be all established this spring! Lastly, CBD Life Sciences Inc. would like to thank all of you for trusting the process and for remaining with the company as it grows into a thriving business with significant, long-term upside potential! The public will be informed regularly throughout all the topics discussed in this letter moving forward.
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
LBC BIOSCIENCE INC. ONLINE STORE
LBC BIOSCIENCE'S Online Emporium
LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices. Check out LBC Bioscience Inc's newest product offerings including its: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
- Large Selection of Products (over 50 items and growing)
100% USA Made Products "organic & kosher."- All Products are THC-FREE (they contain
0.00% THC) - Weekly Deals (new deals every week)
25% off on all products using code "LBC25."
LBC Bioscience Inc. accepts: Visa, MasterCard, American Express, Discover etc.
Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:
LBC Bioscience Inc's Main Website at www.lbcbioscienceinc.com
Twitter: https://www.twitter.com/lbcbioscience
Facebook: https://www.facebook.com/lbcbioscience
Instagram: https://www.instagram.com/lbcbioscience
Amazon: https://www.amazon.com/shops/lbcbioscienceinc
eBay: https://www.ebay.com/usr/lbcbioscience
Alibaba: https://lbcbioscience.trustpass.alibaba.com/
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.
Ten Associates LLC
Contact: Thomas E. Nelson
Telephone: (480) 326-8577
Email: tenassociates33@gmail.com
Website: www.tenassociatesllc.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking
SOURCE: CBD Life Sciences Inc.
View source version on accesswire.com:
https://www.accesswire.com/685481/CBD-Life-Sciences-Inc-CBDL-Releases-Letter-to-Shareholders
FAQ
What is CBD Life Sciences' current strategy for growth?
How has CBD Life Sciences performed with its vending machine initiative?
What are CBD Life Sciences' future expansion plans?
What products does CBD Life Sciences offer?
What are the potential risks associated with CBD Life Sciences' strategies?
